Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2002-11-30
2005-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Family physicians were randomly selected and approached to participate in CHAT. Paired cluster randomization was used, with practices as the unit of randomization. Data on blood pressure (BP) readings in the last year, diagnosis of hypertension, diagnosis of diabetes and/or target organ damage, and a current antihypertensive profile was extracted from the health records of 55 patients randomly selected in each practice. In practices allocated to the Intervention group, physicians sent a letter, with assistance from research staff, to invite all of their eligible patients 65 years and older to attend one or two BP sessions in nearby pharmacies. Inclusion criteria required that patients be regular patients in the practice, community-dwelling, and mobile/well enough to attend community sessions.
Public health authorities trained older adult volunteer peer health educators to assist patients at the sessions to accurately measure their BP using a validated automated device, and record BP readings and cardiovascular risk factors. The volunteers provided education about hypertension but did not perform a clinical function. A recommendation protocol ensured that the pharmacist and, if necessary, the physician was notified if patients had a very high BP or a very low BP accompanied by symptoms. A public health nurse was 'on-call' during the sessions in case clinical advice was needed. A volunteer coordinator facilitated the transfer of readings and patient-reported cardiovascular risk factors to physicians.
Accurate BP readings were obtained from the BPM-100 automated BP measuring device. Questionnaires were used to obtain self-report data on cardiovascular disease risk factors from patients, knowledge and attitudes about BP control from physicians, and attitudes and satisfaction with the program from peer health educators, pharmacists, and public health nurses.
The primary outcome measure followed an 'intention to treat' approach. The primary endpoint was the difference in the change from 12 months pre- to 12 months post-intervention in the proportion of eligible patients with a BP reading recorded in their health record with mean systolic \<=140 mm Hg or mean diastolic \<=90 mmHg; \<=130 or \<=80 if target organ damage or diabetes is present.
This trial is a collaboration by the Department of Family Medicine, McMaster University and the Elisabeth Bruyère Research Institute, a University of Ottawa and SCO Service Partnership.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Volunteer-led pharmacy sessions with feedback to physicians
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-academic (none of its members are full-time faculty members)
* Full-time
* Regular family practice in terms of size and case-mix
* Able to provide an electronic roster that includes a mailing address of their patients 65 years and older
* Community-dwelling
* 65 years or older
* Visited the practice at least once in the last year
* Considered regular patients by the physician
Exclusion Criteria
* about to retire
* work part-time
* fewer than 50 patients 65 years or older
* specialized practice profile
Patients
* Terminally ill
* Scheduled to have surgery during the program period
* Not mobile to visit the pharmacy
* Non-English-speaking and unable to attend with an English-speaking companion
* Significant cognitive impairment
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ottawa
OTHER
Hamilton Health Sciences Corporation
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Janusz A Kaczorowski, PhD
Role: PRINCIPAL_INVESTIGATOR
McMaster University
Larry W Chambers, PhD
Role: PRINCIPAL_INVESTIGATOR
Bruyère Health Research Institute.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McMaster University
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Karwalajtys T, Kaczorowski J, Chambers LW, Levitt C, Dolovich L, McDonough B, Patterson C, Williams JE. A randomized trial of mail vs. telephone invitation to a community-based cardiovascular health awareness program for older family practice patients [ISRCTN61739603]. BMC Fam Pract. 2005 Aug 19;6:35. doi: 10.1186/1471-2296-6-35.
Chambers LW, Kaczorowski J, Levitt C, Karwalajtys T, McDonough B, Lewis J. Blood pressure self-monitoring in pharmacies. Building on existing resources. Can Fam Physician. 2002 Oct;48:1594-5, 1602-4. No abstract available.
Chambers LW, Kaczorowski J, Dolovich L, Karwalajtys T, Hall HL, McDonough B, Hogg W, Farrell B, Hendriks A, Levitt C. A community-based program for cardiovascular health awareness. Can J Public Health. 2005 Jul-Aug;96(4):294-8. doi: 10.1007/BF03405169.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIHR MOP 57902
Identifier Type: -
Identifier Source: secondary_id
McMaster CSD 2001HO4527
Identifier Type: -
Identifier Source: secondary_id
0517-149-02
Identifier Type: -
Identifier Source: org_study_id